Papakonstantinou Stamatina

Papakonstantinou Stamatina Nephrologist

Education & Academic Qualifications

  • 23/09/1996: Graduate of Medical University of Sofia, Bulgaria
  • 23/12/2005: Awarded Nephrology specialty title after exams

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Hellenic Nephrology Society (ENE)

  • European Renal Association – European Dialysis and Transplant Association (ERA-EDTA)

  • International Society of Nephrology (ISN)

 

Work Experience

  • Countryside service, Community Health Center of Siatista, General Hospital of Kozani, 1997 – 1999

  • Residency in Internal Medicine, General Hospital of Veroia, 1999 – 2001

  • Residency in Nephrology, General Hospital of Veroia, 2001- 2005

  • Residency in Renal Transplantation, Hippokration General Hospital of Thessaloniki, Organ Transplant Clinic, 2005

  • Nephrologist, Dialysis Unit, Hygeia Hospital Athens, 2005 – 2009

  • Nephrologist, Nephrology Institute Athens, 2009 – 2012

  • Nephrologist, Scientific partner/contributor, Hygeia Hospital Athens since 2012

 

Clinical & Research Interest

Clinical Interest:

  • Diagnostic approach and treatment of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)

  • Hemodialysis treatment versions (Chronic Dialysis, Acute Dialysis, Continuous Renal Replacement Therapy) 

  • Diagnosis and Treatment of primary and secondary renal diseases

  • Diagnosis and Treatment of Arterial Hypertension

  • Diabetic Nephropathy

  • Metabolic Workup of Renal Lithiasis

  • Geriatric Nephrology

Research Interest:

  • Complications of CKD

  • Renal Anemia

  • Renal Bone Disease, Secondary Hyperparathyroidism

  • Renal Nutrition

Researcher in Greek and International multicenter clinical trials:

  • NESP 20000259 phase IIIb

  • ΜΟ1-367

  • AURORA STUDY

 

Recent Publications

  • Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients, Nephrology, Volume 14 Issue 6, Pages 560 – 564, Published Online: 3 Mar 2009

  • Prevalence of the metabolic syndrome in hemodialysis, Int J Artif Organs 2007 Feb; 30 (2): 118-23

  • Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece, In Vivo January 1, 2009 vol. 23 no. 1, 177-181

  • Characteristics of uremic pruritus in hemodialysis patients: data from a single center, Kidney International (2008) 74, 962; doi:10.1038/ki.2008.359

  • Loss of hepatitis b immunity in hemodialysis patients acquired either naturally or after vaccination, Clinical Nephrology, Volume 68, No. 4/2007

  • Unit dosing of darbepoetin alfa for the treatment of anemia in patients with esrd being switched from recombinant human erythropoietin: results of a phase ΙΙΙb, 27-week, multicenter, open-label study in greek patients, Current Therapeutic Research, vol.66, no 3, May/June 2005

  • A rare case of peritonitis caused by flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis, Geriatric Nephrology and Urology, (2005) 37: 433-436

  • Δέκα χρόνια εμπειρίας στη συνεχή φορητή περιτοναϊκή κάθαρση (ΣΦΠΚ) σε ένα κέντρο δευτεροβάθμιας περίθαλψης, Ελληνική Νεφρολογία 2004; 16 (1): 76-82

  • Υποτροπιάζουσες και de novo σπειραματονεφρίτιδες στο νεφρικό μόσχευμα, Ελληνική Νεφρολογία 2004; 16 (2): 127-135

  • Η εφαρμογή των κατευθυντηρίων οδηγιών στην κλινική πράξη, Ελληνική νεφρολογία 2006; 18 (1): 27-33

 

Ενώνουμε τις δυνάμεις μας για μια νέα εποχή υγείας.

Το site του ΜΗΤΕΡΑ βρίσκεται σε φάση ανανέωσης και μέσα στους επόμενους μήνες θα ενσωματωθεί στο site του ΥΓΕΙΑ (www.hygeia.gr), ώστε να σας προσφέρουμε μια πιο ολοκληρωμένη και ενιαία online εμπειρία.

Σας ευχαριστούμε για την κατανόηση.
Μείνετε συνδεδεμένοι — οι αλλαγές έρχονται σύντομα.